FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2073473301> ?p ?o ?g. }

• W2073473301 endingPage "196" @default.
• W2073473301 startingPage "189" @default.
• W2073473301 abstract "Australian and New Zealand Journal of MedicineVolume 29, Issue 2 p. 189-196 Free Access Targets in hypertension. Going nowhere or gone as far as we can go? G. L. R. Jennings, Corresponding Author G. L. R. Jennings Director, Cardiovascular Medicine, Alfred Hospital; Deputy Director, Baker Medical Research Institute, Melbourne, Vic.Professor G. L. R. Jennings, Alfred and Baker Medical Unit, Alfred Hospital, Commercial Road, Prahran, Melbourne, Vic 3181.Search for more papers by this authorJ. D. Cameron, J. D. Cameron Senior Lecturer (Biomedical Engineering), School of Electronic Engineering, La Trobe University; Senior Associate, Medical Engineering Research, Alfred and Baker Medical Unit, Melbourne, Vic.Search for more papers by this authorA. M. Dart, A. M. Dart Associate Professor, Associate Director (Atherosclerosis), Alfred and Baker Medical Unit, Melbourne, Vic.Search for more papers by this authorC. D. Gatzka, C. D. Gatzka Scientific Research Fellow, Alfred and Baker Medical Unit, Melbourne, Vic.Search for more papers by this authorB. A. Kingwell, B. A. Kingwell NH&MRC Research Fellow, Alfred and Baker Medical Unit, Melbourne, Vic.Search for more papers by this author G. L. R. Jennings, Corresponding Author G. L. R. Jennings Director, Cardiovascular Medicine, Alfred Hospital; Deputy Director, Baker Medical Research Institute, Melbourne, Vic.Professor G. L. R. Jennings, Alfred and Baker Medical Unit, Alfred Hospital, Commercial Road, Prahran, Melbourne, Vic 3181.Search for more papers by this authorJ. D. Cameron, J. D. Cameron Senior Lecturer (Biomedical Engineering), School of Electronic Engineering, La Trobe University; Senior Associate, Medical Engineering Research, Alfred and Baker Medical Unit, Melbourne, Vic.Search for more papers by this authorA. M. Dart, A. M. Dart Associate Professor, Associate Director (Atherosclerosis), Alfred and Baker Medical Unit, Melbourne, Vic.Search for more papers by this authorC. D. Gatzka, C. D. Gatzka Scientific Research Fellow, Alfred and Baker Medical Unit, Melbourne, Vic.Search for more papers by this authorB. A. Kingwell, B. A. Kingwell NH&MRC Research Fellow, Alfred and Baker Medical Unit, Melbourne, Vic.Search for more papers by this author First published: 25 March 2008 https://doi.org/10.1111/j.1445-5994.1999.tb00682.xCitations: 1AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL References 1 Browning RA. Grammarians Funeral quotation 1, p 113. Quoted in The Oxford Dictionary of Quotations. 3rd edn. Oxford : Oxford University Press, 1979. 2 Australian Consensus Statement on the management of hypertension. Med J Aust 1994; 160 (Suppl.): S1– S16. 3 Guidelines Subcommittee of the World Health Organisation-International Society of Hypertension (WHO-ISH). 1999 World Health Organisation-International Society of Hypertension Guidelines for the Management of Hypertension. J Hypertens 1999; 17: 151– 83. 4 National Institutes of Health, National Heart, Lung and Blood Institute. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. NIH Publication 1997; No. 98–4080. 5 SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group. JAMA 1991; 265: 3255– 64. 6 Collins R, Peto R, MacMahon S et al. Blood pressure, stroke and coronary heart disease. Part 2, Short term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 1990; 335: 827– 38. 7 Staessen JA, Fagard R, Thijs L et al. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension (Syst-Eur). Lancet 1997; 350: 757– 64 (Correction: Lancet 1997; 350: 1636). 8 Hansson L, Lindholm LH, Niskanen L et al. Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial. Lancet 1999; 353: 611– 6. 9 Jennings GL, Wong J. Reversibility of left ventricular hypertrophy and malfunction by antihypertensive treatment. In: L Hansson, W Birkenhager (Eds). Yearbook of hypertension. Vol 18. Assessment of hypertensive organ damage. Oxford : Elsevier Science BV, 1997; 184– 223. 10 Verdecchia P, Schillaci G, Borgioni C et al. Ambulatory pulse pressure. A potent predictor of total cardiovascular risk in hypertension. Hypertension 1998; 32: 983– 8. 11 Ohkubo T, Imai Y, Tsuji I et al. Home blood pressure measurement has a stronger predictive power for mortality than does screening blood pressure measurement: a population-based observation in Ohasama, Japan. J Hypertension 1998; 16: 971– 5. 12 Khattar RS, Senior R, Lahiri A. Cardiovascular outcome in ‘white coat’ versus sustained mild hypertension. A 10-year follow-up study. Circulation 1998; 98: 1892– 7. 13 Benetos A, Safar M, Rudnichi A et al. Pulse pressure: a predictor of long-term cardiovascular mortality in a French male population. Hypertension 1997; 30: 1410– 5. 14 Mitchell GF, Moye LA, Braunwald E et al. Sphygmomanometrically determined pulse pressure is a powerful independent predictor of events after myocardial infarction in patients with impaired left ventricular function. SAVE investigators. Survival and Ventricular Enlargement. Circulation 1997; 96: 4254– 60. 15 Dart AM, Lacombe F, Yeoh JK et al. Aortic distensibility in patients with isolated hypercholesterolaemia, coronary artery disease, or cardiac transplant. Lancet 1991; 338: 270– 3. 16 Gatzka CD, Cameron JD, Kingwell BA, Dart AM. Relation between coronary artery disease, aortic stiffness, and left ventricular structure in a population sample. Hypertension 1998; 32: 575– 8. 17 Kass D, Saeki A, Tunin R, Recchia F. Adverse influence of systemic vascular stiffening on cardiac dysfunction and adaptation to acute coronary occlusion. Circulation 1996; 93: 1533– 41. 18 Watanabe H, Ohtsuka S, Kakihana M, Sugishita Y. Coronary circulation in dogs with an experimental decrease in aortic compliance. J Am Coll Cardiol 1993; 21: 1497– 506. 19 McDonald's blood flow in arteries, theoretical, experimental and clinical principles. 3rd edn. WW Nichols, MF O'Rourke (Eds). Philadelphia : Lea & Febiger, 1990; 143– 83, 216–45, 270, 281. 20 Belz GG. Elastic properties and Windkessel function of the human aorta. Cardiovasc Drugs Therapy 1995; 9: 73– 83. 21 Benetos A, Laurent S, Asmar RG et al. Large artery stiffness in hypertension. J Hypertens 1997; 15 (Suppl. 2): S89– S97. 22 Bank AJ. Physiologic aspects of drug therapy and large artery elastic properties. Vasc Med 1997; 2: 44– 50. 23 Cameron JD, Jennings GL, Dart AM. Systemic arterial compliance is decreased in newly diagnosed patients with coronary heart disease: implications for prediction of risk. J Cardiovasc Risk 1996; 3: 495– 500. 24 Kingwell BA, Berry KL, Cameron JD et al. Arterial compliance increases after moderate-intensity cycling. Am J Physiol 1997; 273: H2186– H91. 25 Rajkumar C, Kingwell BA, Cameron JD et al. Hormonal therapy increases arterial compliance in postmenopausal women. J Am Coll Cardiol 1997; 30: 350– 6. 26 Nestel PJ, Pomeroy SE, Sasahara T et al. Arterial compliance in obese subjects is improved with dietary plant n-3 fatty acid from flaxseed oil despite increases LDL oxidisability. Arterio Thromb Vas Biol 1997; 17: 1163– 70. 27 O'Rourke MF, Kelly RP, Avolio AP, Hayward CS. Potential for reversing the ill-effects of aging and of arterial hypertension on central aortic systolic pressure and on left ventricular hydraulic load by arterial dilator agents. Am J Cardiol 1989; 63: 381– 441. 28 Cameron JD, McGrath BP, Dart AM. Use of radial artery applanation tonometry and a generalised transfer function to determine aortic pressure augmentation in subjects with treated hypertension. JACC 1998; 32: 1214– 20. 29 Levy D, Larson MG, Vasan RS et al. The progression from hypertension to congestive heart failure. JAMA 1996; 275: 1557– 62. 30 Hansson L, Zanchetti A, Carruthers SG et al., for The HOT Study Group. Effects of intensive blood pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet 1998; 351: 1755– 62. 31 Adams S. Dilbert's management handbook. New York: Harper Business, 1996; 2: 15. 32 Risk Factor Prevalence Management Committee. Risk Factor Prevalence Survey: Survey No. 3 1989. Canberra : National Heart Foundation of Australia and Australian Institute of Health 1990. 33 Coca A. Actual blood pressure control: are we doing things right J Hypertension 1998; 16 (Suppl. 1): S45– 51. 34 Gamble G, MacMahon S, Culpan A, Ciobo C, Whalley G, Sharpe N. Atherosclerosis and left ventricular hypertrophy: persisting problems in treated hypertensive patients. J Hypertens 1998; 16: 1389– 95. 35 Berlcwitz DR, Ash AS, Hickey EC et al. Inadequate management of blood pressure in a hypertensive population. N Engl J Med 1998; 339: 1957– 63. Citing Literature Volume29, Issue2April 1999Pages 189-196 ReferencesRelatedInformation" @default.
• W2073473301 created "2016-06-24" @default.
• W2073473301 creator A5018614927 @default.
• W2073473301 creator A5025282932 @default.
• W2073473301 creator A5048747672 @default.
• W2073473301 creator A5056267157 @default.
• W2073473301 creator A5082586880 @default.
• W2073473301 date "1999-04-01" @default.
• W2073473301 modified "2023-09-23" @default.
• W2073473301 title "Targets in hypertension. Going nowhere or gone as far as we can go?" @default.
• W2073473301 cites W1965733146 @default.
• W2073473301 cites W1966174203 @default.
• W2073473301 cites W1971511352 @default.
• W2073473301 cites W1983360494 @default.
• W2073473301 cites W2012455579 @default.
• W2073473301 cites W2019717252 @default.
• W2073473301 cites W2023515446 @default.
• W2073473301 cites W2028105762 @default.
• W2073473301 cites W2050727720 @default.
• W2073473301 cites W2053753360 @default.
• W2073473301 cites W2060253215 @default.
• W2073473301 cites W2074561137 @default.
• W2073473301 cites W2084681387 @default.
• W2073473301 cites W2090066747 @default.
• W2073473301 cites W2102979143 @default.
• W2073473301 cites W2114634962 @default.
• W2073473301 cites W2125097212 @default.
• W2073473301 cites W2137408480 @default.
• W2073473301 cites W2139480984 @default.
• W2073473301 cites W2147624902 @default.
• W2073473301 cites W2149816257 @default.
• W2073473301 cites W2160585335 @default.
• W2073473301 cites W2414625847 @default.
• W2073473301 cites W4237999733 @default.
• W2073473301 cites W4249101651 @default.
• W2073473301 doi "https://doi.org/10.1111/j.1445-5994.1999.tb00682.x" @default.
• W2073473301 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10342016" @default.
• W2073473301 hasPublicationYear "1999" @default.
• W2073473301 type Work @default.
• W2073473301 sameAs 2073473301 @default.
• W2073473301 citedByCount "1" @default.
• W2073473301 crossrefType "journal-article" @default.
• W2073473301 hasAuthorship W2073473301A5018614927 @default.
• W2073473301 hasAuthorship W2073473301A5025282932 @default.
• W2073473301 hasAuthorship W2073473301A5048747672 @default.
• W2073473301 hasAuthorship W2073473301A5056267157 @default.
• W2073473301 hasAuthorship W2073473301A5082586880 @default.
• W2073473301 hasBestOaLocation W20734733011 @default.
• W2073473301 hasConcept C177713679 @default.
• W2073473301 hasConcept C71924100 @default.
• W2073473301 hasConceptScore W2073473301C177713679 @default.
• W2073473301 hasConceptScore W2073473301C71924100 @default.
• W2073473301 hasIssue "2" @default.
• W2073473301 hasLocation W20734733011 @default.
• W2073473301 hasLocation W20734733012 @default.
• W2073473301 hasOpenAccess W2073473301 @default.
• W2073473301 hasPrimaryLocation W20734733011 @default.
• W2073473301 hasRelatedWork W1506200166 @default.
• W2073473301 hasRelatedWork W1995515455 @default.
• W2073473301 hasRelatedWork W2039318446 @default.
• W2073473301 hasRelatedWork W2080531066 @default.
• W2073473301 hasRelatedWork W2748952813 @default.
• W2073473301 hasRelatedWork W2899084033 @default.
• W2073473301 hasRelatedWork W3031052312 @default.
• W2073473301 hasRelatedWork W3032375762 @default.
• W2073473301 hasRelatedWork W3108674512 @default.
• W2073473301 hasRelatedWork W4252371801 @default.
• W2073473301 hasVolume "29" @default.
• W2073473301 isParatext "false" @default.
• W2073473301 isRetracted "false" @default.
• W2073473301 magId "2073473301" @default.
• W2073473301 workType "article" @default.